Oncology | CHOP Research Institute
 

Oncology

Published on
May 7, 2025
Using advanced omics and computational techniques, the researchers found that both cancer and immune cells changed after treatment.

This study enrolls patients with refractory, progressive, or relapsed solid tumors.

This study enrolls patients with cancer diagnoses who are expected to be hospitalized (inpatient) for at least 21 days.

Published on
Jan 6, 2025
The CHOP-led trial showed that blinatumomab plus chemotherapy drastically improved survival rates for patients with B-ALL.
Published on
Dec 19, 2024
As the pediatric cancer charity celebrates its 20th anniversary, Cornerstone is highlighting the groundbreaking research at CHOP fueled by two decades of collaboration.

The purpose of this study is to see if a new investigational topical (applied to the skin) formulation of sirolimus, PTX-022 (the study drug), is safe and effective in treating participants with microcystic Lymphatic Malformations.

Published on
Oct 30, 2024
Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.

This study involves taking a study drug called INBRX-109.

This study is enrolling people who have developed lung problems (called Bronchiolitis Obliterans or BO) after hematopoietic stem cell transplant (HSCT).

Published on
Sep 30, 2024
CHOP researchers uncovered 15 subtypes of T-cell acute lymphoblastic leukemia, which will help to predict outcomes and guide treatment.